Top

Category: Biotech


Biotech, Industry

How CRO venture capital relationships can help biotech fundraising

January 18, 2022

Via: Biopharma Dive

Developing drugs is a capital-intensive activity, and never more so than when a biotech company wants to move from preclinical development to more expensive clinical trials. Early on, there are often angel investments and/or academic or government grants, but the […]


Biotech, Industry

COVID Pandemic Prompts Renewed Interest in Biotech Startups

January 12, 2022

Via: Biopharm International

The momentum of biotech and biopharma companies is on the rise in anticipation of a new wave of emerging therapies moving through the industry’s development pipeline. In addition, the COVID-19 pandemic highlighted the importance of companies that can react quickly […]


Biotech, Industry

Merck leans into AI with $610M in biobucks for Absci drug discovery pact

January 7, 2022

Via: FierceBiotech

Merck is taking a deep dive into complex proteins with the help of artificial-intelligence-powered drug discovery company Absci. The two companies have signed a research collaboration for up to three targets in a deal worth up to $610 million in […]


Biotech, Industry

Eikon Therapeutics snares $500M series B, pinning constellation of biotech stars to its upper ranks

January 6, 2022

Via: FierceBiotech

Eikon Therapeutics, the drug discovery startup with a former Merck & Co. research chief at the helm, has appointed a pantheon of biotech veterans on its quest to take its live-cell imaging platform to the next level. The biotech unveiled […]


Biotech, Industry, Manufacturing, Research and Development

Industry Warming to 24/7 Production

December 28, 2021

Via: Genetic Engineering and Biotechnology News

Anton Middelberg, PhD, deputy vice-chancellor and vice-president of research at the University of Adelaide in Australia, believes industry reluctance to go continuous reflects the traditional focus on batch-mode production and, in some areas, the technical challenges. “The complexity in continuous […]


Biotech, Industry, News

2022 forecast: We wish we had better news for biotech dealmaking in 2022, but omicron is coming anyway

December 22, 2021

Via: FierceBiotech

We thought we’d finally get to see what a post-pandemic world looked like in 2022, but thanks to omicron, it seems we’re in for another round. Biotech has been shaped by the pandemic in ways that may be permanent, just […]


Biotech, Industry

A serial biotech entrepreneur launches his next startup with high-dollar backing

December 7, 2021

Via: Biopharma Dive

Gary Glick, a chemist and well-known biotech entrepreneur, has raised more than $200 million to launch the latest company aiming to harness advances in medicinal chemistry to invent new drugs for cancer and inflammatory diseases. Called Odyssey Therapeutics, the startup […]


Biotech, Industry

Biotech Startups Seeing Renewed Interest Following Pandemic

December 1, 2021

Via: Biopharm International

The momentum of biotech and biopharma companies is on the rise in anticipation of a new wave of emerging therapies moving through the industry’s development pipeline. In addition, the COVID-19 pandemic highlighted the importance of companies that can react quickly […]


Biotech, Industry

Biomanufacturing facilities facing persistent malware attack

November 24, 2021

Via: Pharmaphorum

Large biomanufacturing facilities, including some that may be involved in producing COVID-19 vaccines and drugs, are being targeted by a malware threat that seems to have an unprecedented level of sophistication, according to a cybersecurity group. The Bioeconomy Information Sharing […]


Biotech, Industry

Moderna founder unveils new drug company focused on a different kind of RNA

November 9, 2021

Via: Biopharma Dive

Long before we knew how they did it, human cells had refined the process for making proteins, the microscopic workers needed for pretty much everything our bodies do. First, a special enzyme finds the instructions for a protein in our […]


Biotech, Industry

Increasing the Use of Mass Spec in Biomanufacturing

October 12, 2021

Via: Genetic Engineering and Biotechnology News

In October, Chetan Goudar, PhD, vice president at Amgen process development, and his colleagues wrote in Current Opinion in Biotechnology: “Rapid technological advances have significantly improved the capability, versatility, and robustness of mass spectrometers which has led to them playing […]


Biotech, Industry

Bacteriophage and Antibiotic Combined to Fight Drug-Resistant Infection

September 20, 2021

Via: Genetic Engineering and Biotechnology News

Researchers from the Université de Montpellier, France, and the University of Pittsburgh, have published a study (“Mycobacteriophage-antibiotic therapy promotes enhanced clearance of drug-resistant Mycobacterium abscessus”) in Disease Models & Mechanisms that describes the antibacterial effects of treating infections caused by […]